M&A Deal Summary |
|
|---|---|
| Date | 2023-01-10 |
| Target | Monarch PCM |
| Sector | Life Science |
| Buyer(s) | Alora |
| Deal Type | Add-on Acquisition |
SEARCH BY
Alora develops and manufactures pharmaceuticals, including prenatal vitamins, nutraceuticals, dermatologics and innovative products for gastroenterology and endocrinology disorders. Alora maintains a broad portfolio of both branded and non-branded products, focusing on identifying opportunities to acquire and enhance the market potential of commercially available dietary supplement products and late-stage development drugs to fulfill unmet medical and dietary needs. Alora was founded in 2011 and is based in Alpharetta, Georgia.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: Texas M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2023 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-06-25 |
Osmotica Pharmaceuticals - Legacy Business
Bridgewater, New Jersey, United States Osmotica Pharmaceuticals' Legacy Business gives a diverse portfolio and dedication to high-quality branded and generic products focused on ophthalmology and aesthetics |
Buy | $170M |
